References
Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W, Study groupindolent Lymphomas (StiL) (2013) Bendamustine plus rituximab versus CHOP plus rituximabas first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 381(9873):1203–1210
Nishikori M, Kitano T, Kobayashi M, Hishizawa M, Kitawaki T, Kondo T, Yamashita K, Kawabata H, Kadowaki N, Takei Y, Haga H, Takaori-Kondo A (2015) Increased number of peripheral CD8+ T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustine. Int J Hematol 102(1):53–58
Gavini A, Telang GH, Olszewski AJ (2012) Generalized purpuric drug exanthemwithhemorrhagic plaques following bendamustine chemotherapy in a patient withB-prolymphocytic leukemia. Int J Hematol 95(3):311–314
Malipatil B, Ganesan P, Sundersingh S, Sagar TG (2011) Preliminary experience with the use of bendamustine: a peculiar skin rash as the commonest side effect. Hematol Oncol Stem Cell Ther 4(4):157–160
Nishikori M, Kitano T, Kobayashi M, Hishizawa M, Kitawaki T, Kondo T, Yamashita K, Kawabata H, Kadowaki N, Takei Y, Haga H, Takaori-Kondo A (2015) Increased number of peripheral CD8+ T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustine. Int J Hematol 102(1):53–58
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human and Animal Rights
Conducted study did not involve any animal requiring approval for the same.
Conflict of interest
Authors have no conflicts of interest to declare.
Rights and permissions
About this article
Cite this article
Sahu, K.K., Sawatkar, G.U., Jeyaraman, P. et al. Bullae And Blisters: A Rare Case of Bendamustine Skin Toxicity. Indian J Hematol Blood Transfus 32 (Suppl 1), 368–369 (2016). https://doi.org/10.1007/s12288-016-0651-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-016-0651-5